搜尋





搜尋





市場行情
/
股票
/
phat
/

Phathom Pharmaceuticals Inc

PHAT

添加自選

8.930USD

+0.180+2.06%

收盤 07-31 16:00（美東）報價延遲15分鐘

715.03M總市值

虧損本益比TTM

Phathom Pharmaceuticals Inc

8.930

+0.180+2.06%

概覽

財務

分析

公司

財務摘要利潤表資產負債表現金流量表

PHAT 利潤表

您可以在這裡找到Phathom Pharmaceuticals Inc的年度或季度收入報告，以深入了解Phathom Pharmaceuticals Inc的營運、管理效率和表現。

單季報

單季報+年報

單季報

年報

YOY

隱藏空白列

FY2026Q2

FY2026Q1

FY2025Q4

FY2025Q3

FY2025Q2

FY2025Q1

FY2024Q4

FY2024Q3

FY2024Q2

FY2024Q1

FY2023Q4

FY2023Q3

FY2023Q2

FY2023Q1

FY2022Q4

FY2022Q3

FY2022Q2

FY2022Q1

FY2021Q4

FY2021Q3

FY2021Q2

FY2021Q1

FY2020Q4

FY2020Q3

FY2020Q2

FY2020Q1

FY2019Q4

FY2019Q3

FY2019Q2

FY2019Q1

FY2018Q4

FY2018Q3

營業總收入

88.02%74.27M

104.43%58.30M

94.12%57.58M

202.74%49.50M

439.36%39.50M

1391.58%28.52M

4249.56%29.66M

--16.35M

--7.32M

--1.91M

--682.00K

----

營業收入

88.02%74.27M

104.43%58.30M

94.12%57.58M

202.74%49.50M

--39.50M

1391.58%28.52M

4249.56%29.66M

--16.35M

----

--1.91M

--682.00K

----

主營業務成本

199.64%15.10M

222.13%12.00M

100.47%7.65M

162.73%6.19M

266.13%5.04M

774.18%3.72M

2184.43%3.81M

--2.36M

--1.38M

--426.00K

--167.00K

----

營業費用

-14.42%78.24M

-31.29%73.78M

-28.70%63.51M

-27.05%63.58M

8.04%91.43M

49.42%107.38M

26.25%89.08M

144.39%87.15M

166.94%84.62M

138.94%71.87M

51.27%70.56M

-16.15%35.66M

-30.12%31.70M

-20.65%30.08M

41.17%46.64M

28.34%42.53M

28.44%45.36M

12.87%37.91M

-36.99%33.04M

0.94%33.14M

76.41%35.32M

64.83%33.58M

234.16%52.44M

422.60%32.83M

386.30%20.02M

1561.91%20.38M

3379.60%15.69M

2244.03%6.28M

--4.12M

--1.23M

--451.00K

--268.00K

研發費用

-13.92%7.81M

-15.39%7.77M

-12.70%7.49M

-19.16%7.03M

23.05%9.08M

-2.61%9.18M

-35.92%8.58M

-29.11%8.69M

-42.21%7.38M

-17.85%9.43M

-16.00%13.39M

-35.53%12.26M

-32.16%12.76M

-35.00%11.48M

17.67%15.95M

14.52%19.02M

-12.88%18.82M

-14.19%17.66M

-67.47%13.55M

-35.55%16.61M

45.35%21.60M

29.72%20.58M

227.88%41.65M

476.64%25.77M

436.04%14.86M

3598.14%15.87M

90642.86%12.70M

74383.33%4.47M

--2.77M

--429.00K

--14.00K

--6.00K

折舊攤銷及損耗

----

-37.85%110.00K

-36.00%128.00K

-22.00%156.00K

-14.00%172.00K

-17.29%177.00K

0.00%200.00K

65.29%200.00K

62.60%200.00K

46.58%214.00K

19.05%200.00K

-30.86%121.00K

-17.45%123.00K

14.06%146.00K

24.44%168.00K

34.62%175.00K

13.74%149.00K

2.40%128.00K

27.36%135.00K

47.73%130.00K

70.13%131.00K

140.38%125.00K

1666.67%106.00K

4300.00%88.00K

--77.00K

--52.00K

--6.00K

--2.00K

----

--0.00

----

其他營業費用

----

--0.00

---1.20M

---8.00M

----

營業利潤

92.36%-3.96M

80.37%-15.48M

90.02%-5.93M

80.12%-14.07M

32.83%-51.92M

-12.74%-78.86M

14.97%-59.42M

-98.54%-70.80M

-143.84%-77.30M

-132.58%-69.95M

-49.81%-69.88M

16.15%-35.66M

30.12%-31.70M

20.65%-30.08M

-41.17%-46.64M

-28.34%-42.53M

-28.44%-45.36M

-12.87%-37.91M

36.99%-33.04M

-0.94%-33.14M

-76.41%-35.32M

-64.83%-33.58M

-234.16%-52.44M

-422.60%-32.83M

-386.30%-20.02M

-1561.91%-20.38M

-3379.60%-15.69M

-2244.03%-6.28M

---4.12M

---1.23M

---451.00K

---268.00K

淨非營業利息收入（費用）

利息收入

-15.50%1.51M

-34.24%1.74M

-65.70%1.20M

-61.92%1.41M

-50.69%1.79M

-38.79%2.64M

4.84%3.51M

36.43%3.71M

941.38%3.62M

195.41%4.31M

160.14%3.35M

274.66%2.72M

210.71%348.00K

20757.14%1.46M

21350.00%1.29M

8975.00%726.00K

761.54%112.00K

-50.00%7.00K

-62.50%6.00K

-46.67%8.00K

-92.86%13.00K

-98.41%14.00K

-97.14%16.00K

-96.50%15.00K

80.20%182.00K

--878.00K

--559.00K

--429.00K

--101.00K

--0.00

利息費用

-13.79%15.10M

-12.58%15.80M

-11.69%16.42M

-12.85%16.11M

-1.38%17.52M

5.26%18.07M

42.70%18.59M

82.88%18.48M

84.75%17.76M

86.26%17.17M

35.69%13.03M

8.95%10.11M

69.67%9.62M

234.07%9.22M

246.02%9.60M

524.71%9.28M

351.19%5.67M

116.90%2.76M

114.29%2.77M

15.47%1.48M

-0.48%1.26M

72.36%1.27M

24.64%1.29M

-35.38%1.29M

10.99%1.26M

6609.09%738.00K

20680.00%1.04M

49650.00%1.99M

--1.14M

--11.00K

--5.00K

--4.00K

特殊收入（費用）

----

---829.00K

--0.00

---1.20M

---8.00M

----

--0.00

---2.00M

--0.00

-100.00%0.00

100.00%0.00

778.57%95.00K

-292150.00%-81.83M

-334688.89%-60.26M

---82.61M

---14.00K

---28.00K

---18.00K

其他非經營性收入（費用）

84.52%-24.00K

90.91%-2.00K

-110.20%-5.00K

12.50%-7.00K

-2483.33%-155.00K

48.84%-22.00K

450.00%49.00K

95.94%-8.00K

-300.00%-6.00K

-315.00%-43.00K

84.44%-14.00K

-1690.91%-197.00K

250.00%3.00K

385.71%20.00K

-429.41%-90.00K

77.08%-11.00K

-120.00%-2.00K

-600.00%-7.00K

-466.67%-17.00K

-1100.00%-48.00K

--10.00K

0.00%-1.00K

0.00%-3.00K

42.86%-4.00K

--0.00

---1.00K

---3.00K

---7.00K

----

--0.00

----

--0.00

稅前利潤

----

67.80%-30.37M

71.59%-21.15M

64.98%-29.97M

17.10%-75.81M

-13.84%-94.32M

6.43%-74.45M

-97.90%-85.58M

-123.23%-91.45M

-119.10%-82.85M

-44.55%-79.57M

15.36%-43.24M

19.55%-40.97M

7.01%-37.81M

-53.65%-55.05M

-39.36%-51.09M

-39.31%-50.92M

-16.71%-40.66M

33.31%-35.83M

-7.50%-36.66M

-73.22%-36.55M

-73.00%-34.84M

45.19%-53.72M

49.93%-34.10M

75.96%-21.10M

-1509.99%-20.14M

-20149.17%-98.01M

-23386.90%-68.11M

---87.76M

---1.25M

---484.00K

---290.00K

所得稅

----

--0.00

----

除稅後利潤

----

67.80%-30.37M

71.59%-21.15M

64.98%-29.97M

17.10%-75.81M

-13.84%-94.32M

6.43%-74.45M

-97.90%-85.58M

-123.23%-91.45M

-119.10%-82.85M

-44.55%-79.57M

15.36%-43.24M

19.55%-40.97M

7.01%-37.81M

-53.65%-55.05M

-39.36%-51.09M

-39.31%-50.92M

-16.71%-40.66M

33.31%-35.83M

-7.50%-36.66M

-73.22%-36.55M

-73.00%-34.84M

45.19%-53.72M

49.93%-34.10M

75.96%-21.10M

-1509.99%-20.14M

-20149.17%-98.01M

-23386.90%-68.11M

---87.76M

---1.25M

---484.00K

---290.00K

持續經營利潤

----

67.80%-30.37M

71.59%-21.15M

64.98%-29.97M

17.10%-75.81M

-13.84%-94.32M

6.43%-74.45M

-97.90%-85.58M

-123.23%-91.45M

-119.10%-82.85M

-44.55%-79.57M

15.36%-43.24M

19.55%-40.97M

7.01%-37.81M

-53.65%-55.05M

-39.36%-51.09M

-39.31%-50.92M

-16.71%-40.66M

33.31%-35.83M

-7.50%-36.66M

-73.22%-36.55M

-73.00%-34.84M

45.19%-53.72M

49.93%-34.10M

75.96%-21.10M

-1509.99%-20.14M

-20149.17%-98.01M

-23386.90%-68.11M

---87.76M

---1.25M

---484.00K

---290.00K

歸属于母公司的淨利潤

----

67.80%-30.37M

71.59%-21.15M

64.98%-29.97M

17.10%-75.81M

-13.84%-94.32M

6.43%-74.45M

-97.90%-85.58M

-123.23%-91.45M

-119.10%-82.85M

-44.55%-79.57M

15.36%-43.24M

19.55%-40.97M

7.01%-37.81M

-53.65%-55.05M

-39.36%-51.09M

-39.31%-50.92M

-16.71%-40.66M

33.31%-35.83M

-7.50%-36.66M

-73.22%-36.55M

-73.00%-34.84M

45.19%-53.72M

49.93%-34.10M

75.96%-21.10M

-1509.99%-20.14M

-20149.17%-98.01M

-23386.90%-68.11M

---87.76M

---1.25M

---484.00K

---290.00K

歸屬普通股東的淨利潤

----

67.80%-30.37M

71.59%-21.15M

64.98%-29.97M

17.10%-75.81M

-13.84%-94.32M

6.43%-74.45M

-97.90%-85.58M

-123.23%-91.45M

-119.10%-82.85M

-44.55%-79.57M

15.36%-43.24M

19.55%-40.97M

7.01%-37.81M

-53.65%-55.05M

-39.36%-51.09M

-39.31%-50.92M

-16.71%-40.66M

33.31%-35.83M

-7.50%-36.66M

-73.22%-36.55M

-73.00%-34.84M

45.19%-53.72M

49.93%-34.10M

75.96%-21.10M

-1509.99%-20.14M

-20149.17%-98.01M

-23386.90%-68.11M

---87.76M

---1.25M

---484.00K

---290.00K

基本每股收益

79.93%-0.21

71.76%-0.37

72.65%-0.29

69.16%-0.41

33.01%-1.05

7.67%-1.31

24.49%-1.05

-73.87%-1.32

-84.89%-1.56

-58.98%-1.42

-4.16%-1.39

42.13%-0.76

36.52%-0.84

16.49%-0.89

-18.59%-1.33

-7.86%-1.32

-6.24%-1.33

11.40%-1.07

29.37%-1.12

7.28%-1.22

-52.03%-1.25

-50.69%-1.21

58.90%-1.59

52.61%-1.32

75.70%-0.82

-1556.78%-0.80

-20587.91%-3.87

-24695.27%-2.78

---3.39

---0.05

---0.02

---0.01

稀釋每股收益

79.93%-0.21

71.76%-0.37

72.65%-0.29

69.16%-0.41

33.01%-1.05

7.67%-1.31

24.49%-1.05

-73.87%-1.32

-84.89%-1.56

-58.98%-1.42

-4.16%-1.39

42.13%-0.76

36.52%-0.84

16.49%-0.89

-18.59%-1.33

-7.86%-1.32

-6.24%-1.33

11.40%-1.07

29.37%-1.12

7.28%-1.22

-52.03%-1.25

-50.69%-1.21

58.90%-1.59

52.61%-1.32

75.70%-0.82

-1556.78%-0.80

-20587.91%-3.87

-24695.27%-2.78

---3.39

---0.05

---0.02

---0.01

每股派息

----

--0.00

貨幣單位

--USD

審計意見

----

常見問題

如何在 TradingKey 上查看 Phathom Pharmaceuticals Inc 的利潤表？



先看總營收，再依序查看營業成本、毛利、營業費用、營業利益、稅前淨利、淨利和每股盈餘（EPS）。營收反映公司的業務規模，而各項獲利和利潤率則體現公司能否有效地將營收轉化為獲利。

季度利潤表和年度利潤表有什麼區別？



季度利潤表反映公司在一個為期三個月的財務季度內的經營表現，年度損益表則彙總整個財年的業績。季度數據適合用於觀察近期發展勢頭和季節性變化，年度數據則更適合評估長期成長、獲利能力和業務週期。

利潤表頁面中的同比是什麼意思？



同比（即年增率，YoY）是指將某項財務指標與上年同期進行比較，例如將本季度營收與去年同一季度的營收進行對比。與去年同期比較的數據有助於投資者觀察成長趨勢，同時減少正常季節性變化對分析的影響。

分析 PHAT 股票時，哪些利潤表指標最重要？



重要的指標包括營收成長、毛利、毛利率、營業利益、營業利益率、淨利、每股盈餘、研發費用、銷售及管理費用以及所得稅費用。投資者通常會綜合分析這些指標，以判斷公司是否正在成長、有效控制成本並提升獲利能力。

Phathom Pharmaceuticals Inc 財年末的營收是多少？



Phathom Pharmaceuticals Inc 2025 財年營收為 175.11M，高於上一財年的 55.25M。

Phathom Pharmaceuticals Inc 最近一個季度的營收是多少？



Phathom Pharmaceuticals Inc 最近一個季度的營收為 74.27M，同比增長 88.02%。

Phathom Pharmaceuticals Inc 全年的淨利潤是多少？



Phathom Pharmaceuticals Inc 2025 財年淨利潤為 -221.25M。

Phathom Pharmaceuticals Inc 年度營業利潤是多少？



Phathom Pharmaceuticals Inc 2025 財年的營業利潤為 -150.79M。

每股收益與利潤表有什麼關係？



每股收益（EPS）通常以淨利潤除以流通在外的股份數量計算，用於衡量公司平均每股創造的利潤。分析 EPS 時，還應結合股本變化、利潤率、現金流和估值指標進行綜合判斷。